Finance, mergers and appointments
Bayer plans state-of-the-art R&D site in New Albany, Ohio, USA
Bayer plans to build a state-of-the-art site in New Albany, Ohio, USA, to serve local patients as well as...
US $1 billion investment will grow AstraZeneca’s workforce in Massachusetts by over 50% and deliver next-generation medicines
AstraZeneca has opened a new global strategic research and development (R&D) centre, in Kendall Square, Cambridge, Massachusetts, USA.
The new...
Consano Bio raises more than US $15 million in oversubscribed financing to advance C-1101 in chronic painful lumbosacral radiculopathy (chronic sciatica)
Consano Bio, a clinical-stage biotechnology company advancing novel therapeutics designed to address serious, painful orthopaedic conditions, has completed an oversubscribed...
CellCarta establishes strategic partnership with Waters to advance companion diagnostics development
CellCarta, a leading global CRO laboratory to the biopharmaceutical industry, today announced a strategic partnership with Waters Corporation, a...
Ontario contributes $1.7 million investment to advance life sciences innovation at Piramal Pharma’s Aurora facility
Piramal Pharma Solutions (PPS), a leading global contract development and manufacturing organisation (CDMO) has announced that its Aurora, Canada drug...
Evotec announces Chief Scientific Officer transition
Chief Scientific Officer of Evotec SE, Dr Cord Dohrmann, will step down effective 30 September.
The decision for Dr Dohrmann...
Alcami strengthens commercial operations with appointment of Will Isom as Vice President of laboratory services sales
Alcami, a leading contract development and manufacturing organisation (CDMO), has appointed biologics industry veteran Will Isom as Vice President...
Vertex Completes acquisition of Crinetics Pharmaceuticals and announces expansion of executive leadership team
Vertex Pharmaceuticals has successfully acquired Crinetics Pharmaceuticals, a global pharmaceutical company focused on the discovery, development and commercialisation of...
Lilly to acquire Merida Biosciences to advance treatments for serious autoimmune and allergic diseases
Eli Lilly and Merida Biosciences, have announced a definitive agreement for Lilly to acquire Merida.
Merida is developing biologics engineered to selectively degrade pathogenic autoantibodies,...
Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer
Beam Therapeutics has appointed Eric Foster as chief commercial officer.
Mr Foster will lead Beam’s commercial organisation and strategy as...
AbbVie completes acquisition of Apogee Therapeutics
AbbVie has completed the acquisition of Apogee Therapeutics.
With completion of the acquisition, Apogee is now part of AbbVie. Under...
Aurora Cannabis furthers global medical cannabis growth with accretive acquisition of Internode Pharma and HAP Pharma
Aurora Cannabis, the Canadian-based leading global medical cannabis company, has acquired Internode Pharma, a licensed importer and wholesaler and HAP...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
Popular
Recent Posts
Racura Oncology cleared to escalate RC220 to 100 mg/m2 in phase 1 trial in EGFR-mutant non-small cell lung cancer
The Safety Review Committee (SRC) for a clinical trial has cleared Racura Oncology’s lead oncology drug, RC220 to escalate...
Immorta Bio pioneers AI-designed senolytic immunotherapy targeting diseases of aging
Immorta Bio, a biotechnology company pioneering therapies targeting fundamental mechanisms of aging, has completed preclinical studies for SenoMune-0257, an...
Samsung Bioepis and Teva expand strategic partnership to advance up to six potential biosimilar candidates
Samsung Bioepis and Teva Pharmaceutical have entered into a global licence, development and commercialisation agreement for up to six...
Pfizer’s Litfulo significantly improved facial and total body repigmentation in patients with nonsegmental vitiligo
Pfizer has presented results from two phase 3 trials evaluating the efficacy and safety of Litfulo (ritlecitinib) as a...
Novo Nordisk’s Wegovy (semaglutide) reduced liver fat to normal levels in nine out of 10 adults with obesity and excess liver fat – EASD2026
Novo Nordisk has presented post hoc analysis of data from a trial sub-population with 55 participants, showing that Wegovy...
Boehringer Ingelheim’s survodutide achieves up to 13.1% weight loss in new phase 3 trial, alongside significant improvements in glycaemic control in people with obesity...
Boehringer Ingelheim has announced positive results from a phase 3 trial, which investigates the glucagon/GLP-1 receptor dual agonist survodutide...
Biogen’s Litifilimab demonstrates rapid and durable efficacy in new 52-week phase 2 data from ongoing phase 2/3 study, reinforcing its potential as a first-in-class...
Biogen has announced 52-week results from the phase 2 part of the ongoing phase 2/3 study of litifilimab in...
What does it take to turn complex molecules into commercial realities? Drug Discovery and Development’s Leader’s Insight exclusive interview with Angela Ameriks, Chief Commercial Officer of Dishman...
At the heart of pharma, during CPHI Milan 2026, Drug Discovery and Development asks, what it takes to turn complex molecules...
Bayer plans state-of-the-art R&D site in New Albany, Ohio, USA
Bayer plans to build a state-of-the-art site in New Albany, Ohio, USA, to serve local patients as well as...
US $1 billion investment will grow AstraZeneca’s workforce in Massachusetts by over 50% and deliver next-generation medicines
AstraZeneca has opened a new global strategic research and development (R&D) centre, in Kendall Square, Cambridge, Massachusetts, USA.
The new...
Johnson & Johnson announces new Icotyde (icotrokinra) data in difficult-to-treat plaque psoriasis with proven durability through two-years, affirming its use as a powerful first...
Johnson & Johnson has announced new two-year data from a phase 3 study demonstrating the positive impact of Icotyde...
CPHI Milan pharma award winners receive recognition
Every year on the first day of the worldwide show – CPHI Milan – runs the CPHI Celebration, where...
Popular